Eli Lilly (LLY) PT Raised to $95 at Leerink Partners, 'Model Updated to Reflect 2020 Goals; Achievable w/ Pipeline Success'
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $745.69 +1.96%
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Leerink Partners raised its price target on Eli Lilly (NYSE: LLY) to $95.00 (from $93.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Company (SAM) PT Lowered to $325 at Jefferies
- AGNC Investment Corp (AGNC) PT Lowered to $10.25 at Jones Trading
- Halliburton (HAL) PT Raised to $52 at Wolfe Research
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
